Alcohol and Other Drugs

According to the World Health Organization alcohol is the world’s third largest risk factor for disease burden, the leading risk factor in the Western Pacific and the second largest in Europe.

Up to 5.7 percent of the world’s population aged 15 to 64 years use drugs including cannabis, amphetamines, cocaine, opioids and non-prescribed psychoactive prescription medication, with cannabis the most commonly used.

The use of alcohol and other drugs can cause significant health and social problems and can have a major impact on the user’s family and community.

Burnet is committed to addressing the health affects of alcohol and other drug use through the application of behavioural and clinical research, treatment practice and community-based harm reduction programs based on sound evidence.

Donate today!

Use my gift where the need is greatest

Current Projects

  • Attitudes to drug use among East African migrants in Melbourne’s western suburbs

  • Breaking the cycle: supporting people with drug use histories to avoid reincarceration

  • Coping with COVID-19: Young people’s health and wellbeing in Australia

  • CREIDU: Centre for Research Excellence into Injecting Drug Use

  • EDRS: Ecstasy and related Drugs Reporting System

  • Engaging men to improve family health and prevent gender-based violence

  • Evaluation of the Multicultural Drug and Alcohol Service

  • Examining interventions targeting high-risk drinking among young Australians

  • Exploring alcohol and other drug use among migrant communities in Victoria

  • Feasibility study for a potential medically supervised injecting centre/drug consumption service for the ACT

  • IDRS: Illicit Drug Reporting System

  • New media and technology in health promotion practice

  • OST Surveillance Study

  • Sex, Drugs, and Rock'n'Roll (Big Day Out Study)

  • SHARP: Sexual Health And Risk Prevention Study

  • Smart phone Apps for alcohol health promotion

  • SuperMIX: The Melbourne Injecting Drug User Cohort Study

  • The Drug Policy Modelling Program (DPMP)

  • The International Collaboration on Hepatitis C Elimination in HIV Cohorts (InCHEHC)

  • The oral health of people who inject drugs (PWID)

  • The PharmEC REACH study

  • TRYP: Transitions and Risk in Young People project

  • Victorian Pharmaceutical Opioid Monitoring Project

Past Projects

  • PATH Cohort Study